Rating History for Surface Oncology (SURF) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/20/2023 | Swayampakula Ramakanth | Downgrade | Neutral (Buy) |
5.00 (N/A) |
0.79 (1.07) |
35.44% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/20/2023 | Swayampakula Ramakanth | Downgrade | Neutral (Buy) |
5.00 (N/A) |
0.79 (1.07) |
35.44% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||